피임약 시장 규모, 점유율, 성장 분석 : 종류별, 유통 경로별, 지역별 - 업계 예측(2026-2033년)

Contraceptive Drugs Market size was valued at USD 34022.89 Million in 2024 and is poised to grow from USD 36234.38 Million in 2025 to USD 59967.75 Million by 2033, growing at a CAGR of 6.5% during the forecast period (2026-2033).

The contraceptive drugs market is poised for growth driven by rising incidences of sexually transmitted diseases and a significant number of women desiring contraceptive solutions. A considerable global population of women of reproductive age expresses a need for family planning, with millions currently utilizing contraceptive methods while many others remain with unmet demand. Efforts to implement targeted programs aimed at reducing unplanned pregnancies and enhancing awareness around contraceptive options are anticipated to propel market expansion. Nevertheless, concerns regarding side effects such as gastrointestinal issues, weight changes, and emotional effects related to various contraceptive methods may hinder growth. Additionally, the increasing rates of infertility and inconsistent sex education in developed regions pose challenges to the market's advancement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptive Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptive Drugs Market Segments Analysis

Global Contraceptive Drugs Market is segmented by type, distribution and region. Based on type, the market is segmented into oral contraceptives, combined oral contraceptive pills, progestogen-only pills, topical contraceptives, contraceptive injectable and others. Based on distribution, the market is segmented into hospital & clinics, retail pharmacy, online pharmacy and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptive Drugs Market

The prevalence of unintended pregnancies is notably high among poorer and low-income populations globally. A major contributor to this issue is the reliance on traditional contraceptive methods, which are often less effective. This scenario leads to a troubling incidence of unsafe abortions and maternal mortality. In regions such as Latin America, young teenagers face a significantly elevated risk of maternal death compared to older women. Consequently, the adoption of contraceptive drugs plays a vital role in reducing the rates of unplanned pregnancies, thereby improving maternal health outcomes and ensuring better reproductive choices for individuals in these vulnerable groups.

Restraints in the Contraceptive Drugs Market

The contraceptive drugs market faces significant challenges due to the side effects associated with prolonged use of birth control pills, which can include headaches, abnormal bleeding, and nausea. These potential adverse effects, particularly after extended use, raise concerns among consumers. Additionally, medications that contain estrogen and progesterone carry an increased risk of developing blood clots, which can result in serious health complications such as heart attacks. Consequently, these safety concerns contribute to consumer hesitance and may impede the expansion and acceptance of contraceptive pharmaceuticals in the market, limiting its overall growth potential.

Market Trends of the Contraceptive Drugs Market

The contraceptive drugs market is witnessing a significant shift towards technological advancements, particularly with the rise of digital contraception. This innovative approach allows individuals to monitor their menstrual cycles and assess pregnancy risk through online platforms. By leveraging predictive algorithms, digital contraceptive solutions, such as those developed by femtech companies, enable users to make informed decisions about their sexual health, improving prevention strategies and personalizing contraceptive methods. As more consumers become health-conscious and tech-savvy, the demand for digital solutions is anticipated to grow, reshaping the landscape of contraceptive options and enhancing accessibility and user engagement in reproductive health management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Contraceptive Drugs Market Size by Type & CAGR (2026-2033)

• Market Overview
• Oral Contraceptives
• Combined Oral Contraceptive Pills
• Progestogen-Only Pills
• Topical Contraceptives
• Contraceptive Injectable
• Others

Global Contraceptive Drugs Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Hospital & Clinics
• Retail Pharmacy
• Online Pharmacy
• Others

Global Contraceptive Drugs Market Size & CAGR (2026-2033)

• North America (Type, Distribution)
  • USA
  • Canada
• Europe (Type, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HRA Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Famy Care Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinopharm Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations